Announcements Trials
Browse Landscape

Phase

Phase 2 29Phase 1 23Phase NA 16Phase 1/2 6Phase 3 5Phase 2/3 5Phase 4 2Phase EARLY_PHASE1 1

Status

Completed 14Recruiting 9Unknown 8Terminated 6Not yet recruiting 5Active not recruiting 5Withdrawn 1Suspended 1Enrolling by invitation 1

Sponsor Class

OTHER 3INDUSTRY 2

Study Type

Interventional 5

Sponsor

Cancer Type

Head & Neck 2Gastrointestinal 2Tumor-Agnostic 1

Conditions

Neoplasms 7Carcinoma, Hepatocellular 6Neoplasm Metastasis 5Leukemia, Myeloid, Acute 5Colorectal Neoplasms 5Breast Neoplasms 5Stomach Neoplasms 4Rectal Neoplasms 4Recurrence 3Ovarian Neoplasms 3Multiple Myeloma 3Esophageal Squamous Cell Carcinoma 3Carcinoma, Non-Small-Cell Lung 3Triple Negative Breast Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Pancreatic Neoplasms 2Nasopharyngeal Carcinoma 2Hematologic Neoplasms 2Cholangiocarcinoma 2Biliary Tract Neoplasms 2Acute Kidney Injury 2Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Thyroid Carcinoma, Anaplastic 1Thyroid Cancer, Papillary 1Thymoma 1Thymic epithelial tumor 1Squamous NSCLC 1Squamous Cell Non-small Cell Lung Cancer 1Small Cell Lung Carcinoma 1

Interventions

vedolizumab 1Water 1N-dihydrogalactochitosan 1Microwaves 1Injections 1Gemcitabine 1Fluorouracil 1Cisplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 2/3 × Not yet recruiting × Neoplasm Metastasis × Clear all
NCT07509398 2026-04-03

FMT Combined With Standard First-Line Therapy in Initially Unresectable Colorectal Cancer

Shanghai 10th People's Hospital

Phase 2/3 Not yet recruiting
220 enrolled
Gastrointestinal

Neoplasm Metastasis, Colorectal Neoplasms

NCT07321847 2026-01-07

INJECTABL-3

Immunophotonics, Inc.

Phase 2/3 Not yet recruiting
717 enrolled
Gastrointestinal

Neoplasm Metastasis, Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT06719479 2024-12-05

A Clinical Trial to Evaluate Effect of IAE0972 Combined with Chemotherapy for R/M HNSCC or NPC(Note: It is Currently Phase II.).

SUNHO(China)BioPharmaceutical CO., Ltd.

Phase 2/3 Not yet recruiting
60 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Neoplasm Metastasis, Recurrence

NCT06337695 2024-04-02

VERIFY: Vedolizumab for the Prevention of Immune Checkpoint Inhibitor Related Diarrhea or Colitis in Patients With Cancer

University of Calgary

Phase 2/3 Not yet recruiting
298 enrolled
Tumor-Agnostic

Neoplasm Metastasis, Neoplasms

NCT04890522 2021-05-18

An Open-label, Multicentre, Phase II/III RCT of PFLL Versus GP Combined With JS001 as the First-line Therapy for mNPC

Sun Yat-sen University

Phase 2/3 Not yet recruiting
622 enrolled
Head & Neck

Nasopharyngeal Carcinoma, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡